The Azithromycin to Prevent Wheezing following severe RSV bronchiolitis-II clinical trial: Rationale, study design, methods, and characteristics of study population

Authors

• Mythili Srinivasan, Washington University School of Medicine in St. Louis
• Leonard B Bacharier, Washington University School of Medicine in St. Louis
• Charles W Goss, Washington University School of Medicine in St. Louis
• Yanjiao Zhou, University of Connecticut
• Jonathan Boomer, Washington University School of Medicine in St. Louis
• Sarah Bram, Washington University School of Medicine in St. Louis
• Dana Burgdorf, Washington University School of Medicine in St. Louis
• Carey-Ann Burnham, Washington University School of Medicine in St. Louis
• Timothy Casper, Washington University School of Medicine in St. Louis
• Mario Castro, Washington University School of Medicine in St. Louis
• Andrea Coverstone, Washington University School of Medicine in St. Louis
• Matthew Haslam, Washington University School of Medicine in St. Louis
• Watcharoot Kanchongkittiphon, Washington University School of Medicine in St. Louis
• Cadence Kuklinski, Washington University School of Medicine in St. Louis
• Qinghua Lian, Washington University School of Medicine in St. Louis
• Kenneth Schechtman, Washington University School of Medicine in St. Louis
• Gregory A Storch, Washington University School of Medicine in St. Louis
• Kelly true, Washington University School of Medicine in St. Louis
• Meghan A Wallace, Washington University School of Medicine in St. Louis
• Huiqing Yin-DeClue, Washington University School of Medicine in St. Louis
• Elizabeth Ahrens, Washington University School of Medicine in St. Louis
• Jinli Wang, Washington University School of Medicine in St. Louis
• Avraham Beigelman, Washington University School of Medicine in St. Louis

Journal

Contemporary Clinical Trials Communications

Publication Date

6-1-2021

Volume

22

First Page

100798

Document Type

Open Access Publication

DOI

10.1016/j.conctc.2021.100798

Rights and Permissions

Srinivasan M, Bacharier LB, Goss CW, Zhou Y, Boomer J, Bram S, Burgdorf D, Burnham CA, Casper T, Castro M, Coverstone A, Haslam M, Kanchongkittiphon W, Kuklinski C, Lian Q, Schechtman K, Storch GA, True K, Wallace MA, Yin-DeClue H, Ahrens E, Wang J, Beigelman A. The azithromycin to prevent wheezing following severe RSV bronchiolitis-II clinical trial: Rationale, study design, methods, and characteristics of study population. Contemp Clin Trials Commun. 2021 Jun 9;22:100798. doi: 10.1016/j.conctc.2021.100798 © 2021 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Recommended Citation

Srinivasan, Mythili; Bacharier, Leonard B; Goss, Charles W; Zhou, Yanjiao; Boomer, Jonathan; Bram, Sarah; Burgdorf, Dana; Burnham, Carey-Ann; Casper, Timothy; Castro, Mario; Coverstone, Andrea; Haslam, Matthew; Kanchongkittiphon, Watcharoot; Kuklinski, Cadence; Lian, Qinghua; Schechtman, Kenneth; Storch, Gregory A; true, Kelly; Wallace, Meghan A; Yin-DeClue, Huiqing; Ahrens, Elizabeth; Wang, Jinli; and Beigelman, Avraham, "The Azithromycin to Prevent Wheezing following severe RSV bronchiolitis-II clinical trial: Rationale, study design, methods, and characteristics of study population." Contemporary Clinical Trials Communications. 22, 100798 (2021).
https://digitalcommons.wustl.edu/oa_4/617